Latest Breaking News On - Richard staines - Page 3 : comparemela.com

iOnctura awarded UK s MHRA Innovation Passport for entry into innovative licensing and access pathway (ILAP)

iOnctura, a clinical stage biotechnology company developing breakthrough therapies for patients suffering with cancer, today announces that the innovative medicine designation, the Innovation Passport, has been awarded for roginolisib, for the.

United kingdomNoord hollandUnited statesCatherine pickeringMary clark richard stainesDevelopment profileB future health fundCancer research communicationsRegulatory agencyStrategic communicationsInnovation passportInnovative licensingAccess pathwayChief executive officerRichard stainesInkef capital

Verona Pharma to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update

21.02.2023 - LONDON and RALEIGH, N.C., Feb. 21, 2023 (GLOBE NEWSWIRE) - Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial .

United statesUnited kingdomKimberly minarovich carrie mckimVerona pharmaStrategic communicationsInternational mediaKingdom telSenior directorInvestor relationsCarrie mckimEuropean investor enquiriesRichard staines

Clinical trends for 2023

After the tragedies of the COVID-19 pandemic and the Ukraine war, there’s hope that 2023 will see a new wave of clinical research.

United statesSan franciscoVan rijnPeter van rijnKlaas zuideveldHong kong insilicoEli lillyCatherine pickeringAisa pharmaRichard stainesIan wilsonVladimir putinTom burtMorgan stanleyCenters for medicare medicaid servicesStrategic communications

Verona Pharma (VRNA) Reports Ensifentrine Meets Primary and Key Secondary Endpoints in Phase 3 ENHANCE-1 Trial

Verona Pharma (VRNA) Reports Ensifentrine Meets Primary and Key Secondary Endpoints in Phase 3 ENHANCE-1 Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKimberly minarovich carrie mckimDavid zaccardelliVerona pharmaAntonio anzuetoDrug administrationStrategic communications international mediaForced expiratory volumeEvaluating respiratory symptomsRespiratory questionnaireSouth texas veterans healthcare systemChief executive officerNew drug applicationNorth americaInvestor relationsStrategic communications

Verona Pharma plc (VRNA) set to report top-line Phase 3 data from its ENHANCE-1 trial

Verona Pharma plc (VRNA) set to report top-line Phase 3 data from its ENHANCE-1 trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKimberly minarovich carrie mckimVerona pharmaStrategic communications international mediaWall streetInvestor relationsStrategic communicationsInternational mediaEuropean investor enquiriesRichard staines